Editorial
Published on 17 May 2024
Editorial: Anti-inflammatory drug development focusing on immune mediated diseases
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1413141
Type at least 3 characters
22,651 articles
Articles
Systematic Review
Published on 17 May 2024
Efficacy and safety of FLT3 inhibitors in monotherapy of hematological and solid malignancies: a systemic analysis of clinical trials
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1294668
Original Research
Published on 17 May 2024
Benserazide, a cystathionine beta-synthase (CBS) inhibitor, potentially enhances the anticancer effects of paclitaxel via inhibiting the S-sulfhydration of SIRT1 and the HIF1-α/VEGF pathway
in Experimental Pharmacology and Drug Discovery
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1404532
Original Research
Published on 17 May 2024
To elucidate the mechanism of “Scrophulariae Radix–Fritillaria” in goiter by integrated metabolomics and serum pharmaco-chemistry
in Experimental Pharmacology and Drug Discovery
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1206718
Clinical Trial
Published on 17 May 2024
A single-dose, randomized, open-label, four-period, crossover equivalence trial comparing the clinical similarity of the proposed biosimilar rupatadine fumarate to reference Wystamm® in healthy Chinese subjects
in Drug Metabolism and Transport
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1328142
Original Research
Published on 17 May 2024
Repeated epidural delivery of Shinbaro2: effects on neural recovery, inflammation, and pain modulation in a rat model of lumbar spinal stenosis
in Experimental Pharmacology and Drug Discovery
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1324251
Original Research
Published on 17 May 2024
GDF-15 is a potential candidate biomarker for an elevated risk of cardiotoxicity in breast cancer patients receiving neoadjuvant dual anti-HER2 therapy
in Experimental Pharmacology and Drug Discovery
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1396133
Review
Published on 17 May 2024
The structure and function of FUN14 domain-containing protein 1 and its contribution to cardioprotection by mediating mitophagy
in Cardiovascular and Smooth Muscle Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1389953
Original Research
Published on 17 May 2024
Research trends in lipid-lowering therapies for coronary heart disease combined with hyperlipidemia: a bibliometric study and visual analysis
in Cardiovascular and Smooth Muscle Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1393333
Original Research
Published on 17 May 2024
LP340, a novel histone deacetylase inhibitor, decreases liver injury and fibrosis in mice: role of oxidative stress and microRNA-23a
in Gastrointestinal and Hepatic Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1386238
Review
Published on 17 May 2024
Potential application of traditional Chinese medicine in age-related macular degeneration—focusing on mitophagy
in Ethnopharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1410998
Review
Published on 17 May 2024
Emerging biologic frontiers for Sjogren’s syndrome: Unveiling novel approaches with emphasis on extra glandular pathology
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1377055
Original Research
Published on 17 May 2024
Upregulation of GOLPH3 mediated by Bisphenol a promotes colorectal cancer proliferation and migration: evidence based on integrated analysis
in Predictive Toxicology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1337883
Original Research
Accepted on 16 May 2024
Network analysis combined with experimental assessment to explore the therapeutic mechanisms of new shenqi pills formula targeting mitochondria on senile diabetes mellitus
in Ethnopharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1339758
Mini Review
Accepted on 16 May 2024
Novel targets and therapies of metformin in dementia: Old drug, new insights
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1415740
Review
Accepted on 16 May 2024
Understanding Copy Number Variations through their Genes: a Molecular View on 16p11.2 Deletion and Duplication Syndromes
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1407865